Data updated: Mar 10, 2026
ETHACRYNIC ACID
ETHACRYNIC ACID
Approved 2016-06-30
10
Indications
--
Phase 3 Trials
9
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2016-06-30
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
PH HEALTH SCIEGEN PHARMS CHARTWELL RX ALVOGEN Hikma AMNEAL PHARMS CO AGNITIO ADAPTIS Lupin UPSHER SMITH LABS
Active Ingredient: ETHACRYNIC ACID
Website: ↗
ETHACRYNIC ACID Approval History
Loading approval history...
What ETHACRYNIC ACID Treats
10 FDA approvalsOriginally approved for its first indication in 2016 . Covers 10 distinct patient populations.
- Other (10)
Other
(10 approvals)- • Approved indication (Jun 2016)Label Letter
- • Approved indication (Feb 2017)
- • Approved indication (Jul 2017)
- • Approved indication (May 2018)
- • Approved indication (Jul 2018)
- • Approved indication (Jul 2019)
- • Approved indication (Aug 2019)
- • Approved indication (Sep 2019)
- • Approved indication (Feb 2020)
- • Approved indication (Oct 2020)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ETHACRYNIC ACID FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.